Cargando…

Radiotranscriptomics signature‐based predictive nomograms for radiotherapy response in patients with nonsmall cell lung cancer: Combination and association of CT features and serum miRNAs levels

PURPOSE: We aimed to establish radiotranscriptomics signatures based on serum miRNA levels and computed tomography (CT) texture features and develop nomogram models for predicting radiotherapy response in patients with nonsmall cell lung cancer (NSCLC). METHODS: We first used established radioresist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Liyuan, Cao, Qiang, Ding, Xiuping, Gao, Dongni, Yang, Qiwei, Li, Baosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367624/ https://www.ncbi.nlm.nih.gov/pubmed/32458566 http://dx.doi.org/10.1002/cam4.3115

Ejemplares similares

A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography
por: Oikonomou, Evangelos K, et al.
Publicado: (2019)

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
por: Kotanidis, Christos P, et al.
Publicado: (2022)

Clinical value of integrated‐signature miRNAs in esophageal cancer
por: Zhang, Heng‐Chao, et al.
Publicado: (2017)

A meta‐analysis: microRNAs’ prognostic function in patients with nonsmall cell lung cancer
por: Yu, Na, et al.
Publicado: (2017)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Prediction of radiotherapy response with a 5‐microRNA signature‐based nomogram in head and neck squamous cell carcinoma
por: Chen, Lin, et al.
Publicado: (2018)

The correlation of circulating pro‐angiogenic miRNAs’ expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer
por: Peng, Wei, et al.
Publicado: (2018)

Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway
por: Wang, Yingying, et al.
Publicado: (2021)

Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
por: Saitoh, Jun‐ichi, et al.
Publicado: (2019)

A six-gene-based signature for breast cancer radiotherapy sensitivity estimation
por: Chen, Xing, et al.
Publicado: (2020)

Deep Radiotranscriptomics of Non-Small Cell Lung Carcinoma for Assessing Molecular and Histology Subtypes with a Data-Driven Analysis
por: Trivizakis, Eleftherios, et al.
Publicado: (2021)

The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population
por: Li, Chuanyin, et al.
Publicado: (2018)

Disparate outcomes in nonsmall cell lung cancer by immigration status
por: Chau, Brittney, et al.
Publicado: (2021)

Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
por: Hu, Maogui, et al.
Publicado: (2021)

Defining fallopian tube‐derived miRNA cancer signatures
por: Dejene, Selam B., et al.
Publicado: (2019)

Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan‐cancer
por: Chen, Zhanghan, et al.
Publicado: (2020)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
por: Mehta, Anurag, et al.
Publicado: (2019)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

Differential expression of miRNAs in the serum of patients with high-risk oral lesions
por: MacLellan, Sara Ann, et al.
Publicado: (2012)

Expression Analysis of miRNAs and Their Potential Role as Biomarkers for Prostate Cancer Detection
por: Bergez-Hernández, Fernando, et al.
Publicado: (2022)

Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
por: Ye, Ting, et al.
Publicado: (2019)

Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data
por: Xu, Song, et al.
Publicado: (2020)

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world
por: Shokoohi, Aria, et al.
Publicado: (2021)

Identification of Autophagy Related circRNA-miRNA-mRNA-Subtypes Network With Radiotherapy Responses and Tumor Immune Microenvironment in Non-small Cell Lung Cancer
por: Fan, Liyuan, et al.
Publicado: (2021)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

A gene expression signature‐based nomogram model in prediction of breast cancer bone metastases
por: Zhao, Chenglong, et al.
Publicado: (2018)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer
por: Wu, Jing, et al.
Publicado: (2020)

An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity
por: Gholami, Morteza, et al.
Publicado: (2020)

Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis
por: Li, Kejun, et al.
Publicado: (2022)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
por: Hu, Mei-Di, et al.
Publicado: (2019)

Serum SP70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer
por: Liu, Jingping, et al.
Publicado: (2018)

Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
por: Hellmann, Matthew D., et al.
Publicado: (2020)

A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1
por: Longqiu, Yang, et al.
Publicado: (2016)

MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma
por: Tian, Yutong, et al.
Publicado: (2020)

MiRNA-423 rs6505162 and miRNA-6811 rs2292879 SNP associated with lung cancer in Hainan, China
por: Zhou, Jing, et al.
Publicado: (2023)

Next‐generation sequencing of miRNAs in clinical samples of Epstein–Barr virus‐associated B‐cell lymphomas
por: Sakamoto, Kouta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_605tjbf4kpru5d5htjhs9aqhi3